prikaz prve stranice dokumenta Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements
  Preuzmi
PDF 1.21 MB
Znanstveni rad - Izvorni znanstveni rad
Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements
Canadian Journal of Gastroenterology and Hepatology, 2021 (2021); 6670065. https://doi.org/10.1155/2021/6670065
Mikolašević, Ivana; Poropat, Goran; Filipec Kanižaj, Tajana; Skenderević, Nadija; Zelić, Marko; Matašin, Marija; Vranić, Luka; Kresović, Andrea; Hauser, Goran

Citiranost:
,
Citirajte ovaj rad

Mikolašević, I., Poropat, G., Filipec Kanižaj, T., Skenderević, N., Zelić, M., Matašin, M. ... Hauser, G. (2021). Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements. Canadian Journal of Gastroenterology and Hepatology, 2021.. doi: 10.1155/2021/6670065

Mikolašević, Ivana, et al. "Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements." Canadian Journal of Gastroenterology and Hepatology, vol. 2021, 2021. https://doi.org/10.1155/2021/6670065

Mikolašević, Ivana, Goran Poropat, Tajana Filipec Kanižaj, Nadija Skenderević, Marko Zelić, Marija Matašin, Luka Vranić, Andrea Kresović i Goran Hauser. "Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements." Canadian Journal of Gastroenterology and Hepatology 2021 (2021). https://doi.org/10.1155/2021/6670065

Mikolašević, I., et al. (2021) 'Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements', Canadian Journal of Gastroenterology and Hepatology, 2021. doi: 10.1155/2021/6670065

Mikolašević I, Poropat G, Filipec Kanižaj T, Skenderević N, Zelić M, Matašin M, i sur.. Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements. Canadian Journal of Gastroenterology and Hepatology [Internet]. 23.02.2021. [pristupljeno 23.04.2025.];2021. doi: 10.1155/2021/6670065

I. Mikolašević, et al., "Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements", Canadian Journal of Gastroenterology and Hepatology, vol. 2021, Veljača 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:264:909906. [Citirano: 23.04.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:264:909906
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis : controlled attenuation parameter and liver stiffness measurements
AutorIvana Mikolašević
AutorGoran Poropat
AutorTajana Filipec Kanižaj
AutorNadija Skenderević
AutorMarko Zelić
AutorMarija Matašin
AutorLuka Vranić
AutorAndrea Kresović
AutorGoran Hauser
Autorova ustanova(Klinička bolnica Merkur)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Aim. Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). Methods. In this prospective, cross-sectional study, we have evaluated 937 patients with one or more components of the metabolic syndrome who had an esophagogastroduodenoscopy (EGD) due to GERD symptoms. In all patients, a laboratory analysis, an abdominal... Više ultrasound, and FibroScan measurements were done. GERD was defined by EGD. Results. )e mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m2 . The prevalence of increased CAP was 82.6% (774/937). Patients with increased CAP were younger, were more obese, had higher prevalence of hypertension, diabetes, and dyslipidemia, and had higher values of aminotransferases. Similar results of higher prevalence in patients with elevated CAP were observed with GERD, hiatal hernia, and insufficient cardia (defined as deficient or absent closure of the gastric inlet in relation to the esophagus). Additionally, patients with elevated CAP had a higher prevalence of GERD grades B and C in comparison to those without elevated CAP. Consequently, patients who did not have elevated CAP had a higher prevalence of GERD grade A. Even though we have found an upward trend in the prevalence of GERD, hiatal hernia, and insufficient cardia, there was no significant difference between subjects with fibrosis (F) 1-2 and F3-4 stage of fibrosis or F1 and F2-4. In a binary logistic regression, a significant positive association with GERD was obtained for CAP. Furthermore, a significant positive association with hiatal hernia was obtained for BMI and CAP. Finally, a significant positive association with hiatal hernia was obtained with CAP in multivariate analysis. Conclusion. To the best of our knowledge, our study is the first to reveal a positive association between CAP as a surrogate marker of liver steatosis and GERD after adjustments for other clinical variables. Sakrij dio sažetka
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCanadian Journal of Gastroenterology and Hepatology
Brojčani podacivol. 2021, 6670065
p-ISSN2291-2789
e-ISSN2291-2797
DOIhttps://doi.org/10.1155/2021/6670065
URN:NBNurn:nbn:hr:264:909906
Datum objave elektroničkog izdanja2021-02-23
URL dokumentahttps://www.hindawi.com/journals/cjgh/2021/6670065/
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2021-07-02 11:32:20
accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.